-
1
-
-
77953593318
-
HFSA 2010 comprehensive heart failure practice guideline
-
Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010; 16: e1–e194.
-
(2010)
J Card Fail
, vol.16
, pp. e1-e194
-
-
Lindenfeld, J.1
Albert, N.M.2
Boehmer, J.P.3
-
2
-
-
33746088001
-
Trends in prevalence and outcome of heart failure with preserved ejection fraction
-
Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251–259.
-
(2006)
N Engl J Med
, vol.355
, pp. 251-259
-
-
Owan, T.E.1
Hodge, D.O.2
Herges, R.M.3
-
3
-
-
70349231338
-
Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy
-
Stolen TO, Hoydal MA, Kemi OJ, et al. Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res 2009; 105: 527–536.
-
(2009)
Circ Res
, vol.105
, pp. 527-536
-
-
Stolen, T.O.1
Hoydal, M.A.2
Kemi, O.J.3
-
4
-
-
84870556584
-
What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?
-
Campbell RT, Jhund PS, Castagno D, et al. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol 2012; 60: 2349–2356.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 2349-2356
-
-
Campbell, R.T.1
Jhund, P.S.2
Castagno, D.3
-
5
-
-
33748988737
-
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
-
Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338–2345.
-
(2006)
Eur Heart J
, vol.27
, pp. 2338-2345
-
-
Cleland, J.G.1
Tendera, M.2
Adamus, J.3
-
6
-
-
84867745957
-
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial
-
Solomon SD, Zile M, Pieske B, et al. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial. Lancet 2012; 380: 1387–1395.
-
(2012)
Lancet
, vol.380
, pp. 1387-1395
-
-
Solomon, S.D.1
Zile, M.2
Pieske, B.3
-
7
-
-
0041408234
-
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
-
Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777–781.
-
(2003)
Lancet
, vol.362
, pp. 777-781
-
-
Yusuf, S.1
Pfeffer, M.A.2
Swedberg, K.3
-
8
-
-
77950223587
-
Mode of death in patients with heart failure and a preserved ejection fraction: Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial
-
Zile MR, Gaasch WH, Anand IS, et al. Mode of death in patients with heart failure and a preserved ejection fraction: Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 2010; 121: 1393–1405.
-
(2010)
Circulation
, vol.121
, pp. 1393-1405
-
-
Zile, M.R.1
Gaasch, W.H.2
Anand, I.S.3
-
9
-
-
84874367056
-
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The Aldo-DHF randomized controlled trial
-
Edelmann F, Wachter R, Schmidt AG, et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The Aldo-DHF randomized controlled trial. JAMA 2013; 309: 781–791.
-
(2013)
JAMA
, vol.309
, pp. 781-791
-
-
Edelmann, F.1
Wachter, R.2
Schmidt, A.G.3
-
10
-
-
84898713808
-
Spironolactone for heart failure with preserved ejection fraction
-
Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014; 370: 1383–1392.
-
(2014)
N Engl J Med
, vol.370
, pp. 1383-1392
-
-
Pitt, B.1
Pfeffer, M.A.2
Assmann, S.F.3
-
11
-
-
84868203473
-
EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations
-
Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012; 126: 2261–2274.
-
(2012)
Circulation
, vol.126
, pp. 2261-2274
-
-
Guazzi, M.1
Adams, V.2
Conraads, V.3
-
12
-
-
80054768603
-
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study
-
Edelmann F, Gelbrich G, Dungen HD, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 2011; 58: 1780–1791.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1780-1791
-
-
Edelmann, F.1
Gelbrich, G.2
Dungen, H.D.3
-
13
-
-
34548525319
-
How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
-
Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539–2550.
-
(2007)
Eur Heart J
, vol.28
, pp. 2539-2550
-
-
Paulus, W.J.1
Tschope, C.2
Sanderson, J.E.3
-
14
-
-
84903170344
-
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: B2960–B2984.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. B2960-B2984
-
-
Eckel, R.H.1
Jakicic, J.M.2
Ard, J.D.3
-
15
-
-
84882870551
-
Exercise standards for testing and training: A scientific statement from the American Heart Association
-
Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 2013; 128: 873–934.
-
(2013)
Circulation
, vol.128
, pp. 873-934
-
-
Fletcher, G.F.1
Ades, P.A.2
Kligfield, P.3
-
17
-
-
80051994560
-
Telemedicine and remote management of patients with heart failure
-
Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 2011; 378: 731–739.
-
(2011)
Lancet
, vol.378
, pp. 731-739
-
-
Anker, S.D.1
Koehler, F.2
Abraham, W.T.3
-
18
-
-
77955173009
-
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association
-
Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association. Circulation 2010; 122: 406–441.
-
(2010)
Circulation
, vol.122
, pp. 406-441
-
-
Artinian, N.T.1
Fletcher, G.F.2
Mozaffarian, D.3
-
19
-
-
64249125022
-
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
-
O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301: 1439–1450.
-
(2009)
JAMA
, vol.301
, pp. 1439-1450
-
-
O'Connor, C.M.1
Whellan, D.J.2
Lee, K.L.3
|